← Back to All Filings

CME Group Director Files Intent to Sell ~$2M in Stock

Low SignificanceNovember 20, 2025 at 3:32:02 PM EST

CME GROUP INC.

$CME144CIK: 0001156375

Subscribe to track CME

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

CME Group Director Files Intent to Sell ~$2M in Stock

Company: CME GROUP INC. (CME) Form: 144 | Filed: 2025-11-20 Significance: Low

Insider: Sammann Derek Title: Director | Relationship: Director

Transaction (Proposed): • Type: Sale • Shares: 7,200 • Value: ~$1,979,928 • Price/Share: ~$274.99

Key Insight: This proposed sale by a director represents a negligible fraction (0.0019%) of the company's $102.79B market cap. The transaction is considered routine and has low market significance.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: CME GROUP INC. (CME)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director at CME Group has filed a notice of proposed sale for approximately $2 million worth of stock, a transaction that is immaterial relative to the company's large market capitalization.
  • Market Impact: The transaction is not expected to have any meaningful impact on the stock price due to its small size.

Company Information

FieldValue
CompanyCME GROUP INC.
Ticker SymbolCME
CIK0001156375
IndustrySecurity & Commodity Brokers, Dealers, Exchanges & Services

Insider Information

FieldValue
NameSammann Derek
CIK0001475318
Title/PositionDirector
RelationshipDirector

Transaction Details

FieldValue
Form Type144
Transaction Date2025-11-20 (Approximate Sale Date)
Transaction CodeS
Security TypeCommon Class A
Shares Involved7,200
Price Per Share~$274.99 (calculated)
Total Value$1,979,928
Shares Owned AfterNot specified
Ownership TypeIndirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$1,979,928
% of Market Cap0.0019%
Shares Transacted7,200
% of Shares Outstanding0.0020%
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a mega-cap company like CME Group with a market capitalization of $102.79 billion, a transaction of just under $2 million is financially insignificant.
  • Transaction Significance: The sale represents a minuscule percentage of both the market cap and the total shares outstanding, falling far below the thresholds for moderate or high significance. It is likely a routine transaction for personal financial management or diversification, especially given the shares were acquired via employee compensation.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The size of the proposed sale is too small to influence market sentiment or trading activity for a stock of CME's scale.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The 7,200 shares are a tiny fraction of the stock's typical daily trading volume.
  • Sentiment Indicator: Neutral. This filing does not provide any new information that would alter investor perception of the company's fundamentals.

Additional Context

Transaction Notes

  • Source of Shares: The filing indicates the shares were originally acquired as employee compensation, which is a common reason for insider sales.
  • Ownership Structure: The sale is being conducted through two trusts for which the insider is a trustee, indicating indirect ownership.
Topics:#SECFiling#InsiderTrading#CME#CMEGroup#Form144#StockSale#MarketAnalysis#Investing#Finance

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.